Muromonab-CD3

Muromonab-CD3 is an immunosuppressive drug that works by blocking the function of T lymphocytes.

It is used in people who have received a transplant, both to prevent rejection in high-risk patients (induction therapy), and to treat severe rejection resistant to usual corticosteroid therapy.

Muromonab-CD3 is a murine monoclonal antibody of the IgG2a type that was created using hybridoma technology. It recognizes the CD3 molecule found on the surface of T lymphocytes. It is an antibody widely used in medicine and molecular biology in the field of immunology.

wiki